The blockade of DAT generates an augmentation of dopamine in the synaptic cleft, improving neurological function disorders involved with emotional approaches, such as learning disabilities, anxiety, anhedonia, and depression [5]. This evidence concerns the gene SLC6A3 and Anxiety.